Polifeprosan 20, 3.85% Carmustine Slow-Release Wafer in Malignant Glioma: Evidence for Role in Era of Standard Adjuvant Temozolomide

Core Evidence - New Zealand
doi 10.2147/ce.s23244
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search